Exploring the impact of insurance switching on the cost-effectiveness of population genetic screening for familial hypercholesterolemia to US payers is a research paper published in Journal of clinical lipidology (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: UM1TR004406
U.S. Department of Health and Human Services
AstraZeneca
Bristol-Myers Squibb
Muscular Dystrophy Canada
National Institutes of Health
MeSH Terms
Keywords